Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Gynecol Oncol. 2013 May 28;130(3):629–633. doi: 10.1016/j.ygyno.2013.05.028

Table 2.

Antibodies to HE4 in archived sera from patients with OvC and controls.

Positive sera at dilution
1:20
Positive sera at dilution 1:100
Serum donor n M+2SD M+3SD M+1SD M+2SD M+3SD

n % pos n % pos n % pos n % pos n % pos
Controls 71 3 4 1 1 3 4 2 3 2 3
All OvC patients 92 9 10 8 9* 20 22*** 1 14** 1 12*
3 1
OvC stage I/II 17 2 12 1 6 4 27* 3 20* 2 13
OvC stage III/IV 75 6 8 4 5 16 21** 9 12* 8 11*
*

p<0.05

**

p<0.01

***

p<0.001